Compare ARK Genomic Revolution ETF (ARKG) vs Xcel Energy Inc (XEL) Price & Performance
Price performance
Price movement over the last 24 hours
Key statistics
Key statistics
ARK Genomic Revolution ETF vs Xcel Energy Inc — how do they compare? ARK Genomic Revolution ETF trades at $40.83, while Xcel Energy Inc trades at $80.06 (market cap $49.98B). The key difference: Xcel Energy Inc pays a 2.96% dividend while ARK Genomic Revolution ETF pays none, and ARK Genomic Revolution ETF is trading nearer its 52-week high, Xcel Energy Inc nearer its low. Which is the better fit depends on your goals.
| ARKG | XEL | |
|---|---|---|
Sector | Sector/Thematic | Utilities |
52-Week High | $43.57 | $83.91 |
52-Week Low | $23.09 | $68.33 |
Market Cap | — | $49.98B |
Enterprise Value | — | $87.42B |
Dividend Yield | — | 2.96% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
ARKG trades at $41.32, down 3.91% today, with a bullish technical signal driven by moving averages. Recent news highlights biotech ETF strength in June 2026, fueled by strong earnings, M&A activity, and AI-driven drug discovery optimism. Key support lies at $40, with resistance at $44.
The outlook remains positive given sector tailwinds, but risks include regulatory hurdles and market volatility. Investor sentiment is buoyed by industry growth catalysts, though selective investment approaches are noted by analysts.
XEL trades at $80.06, up 1.32% today, with a bearish technical signal but strong analyst consensus. Recent earnings showed a Q1 2026 beat but two prior misses. The company maintains solid fundamentals with $14.67B revenue, 14.14% net margin, and a $60B capital plan driving growth. Dividend yield is 2.87% with a recent $0.59 payout declared.
Outlook is positive with Wall Street's $91.88 price target suggesting 15% upside, supported by data center demand and infrastructure investments. Risks include regulatory pushback on rate hikes and high debt levels. The stock presents a steady utility play with growth catalysts but requires monitoring of earnings consistency and capex execution.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About ARK Genomic Revolution ETF
ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.
Read more on ARKG →About Xcel Energy Inc
Xcel Energy manages utilities serving 3.7 million electric customers and 2.1 million natural gas customers in eight states. Its utilities are Northern States Power, which serves customers in Minnesota, North Dakota, South Dakota, Wisconsin, and Michigan
Read more on XEL →
